Sinopharm Group Co. Ltd.
SHTDY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54,313,359 | $63,808,538 | $55,221,624 | $43,529,428 |
| Short-Term Investments | $158 | $547 | $498 | $11,749 |
| Receivables | $206,721,120 | $185,790,359 | $171,204,072 | $172,575,535 |
| Inventory | $62,352,812 | $60,027,648 | $60,925,831 | $51,499,625 |
| Other Curr. Assets | $24,060,122 | $27,208,008 | $32,054,357 | $23,305,804 |
| Total Curr. Assets | $347,447,571 | $336,835,100 | $319,406,382 | $290,922,141 |
| Property Plant & Equip (Net) | $19,632,440 | $19,897,657 | $17,792,353 | $17,597,506 |
| Goodwill | $6,251,565 | $7,185,729 | $7,155,580 | $7,199,009 |
| Intangibles | $4,717,685 | $2,830,402 | $4,870,150 | $5,002,964 |
| Long-Term Investments | $10,894,141 | $10,550,686 | $9,839,962 | $9,172,530 |
| Tax Assets | $2,408,387 | $0 | $1,979,743 | $1,787,093 |
| Other NC Assets | $1,479,455 | $6,095,270 | $3,730,964 | $3,731,078 |
| Total NC Assets | $45,383,673 | $46,559,744 | $45,368,752 | $44,490,180 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $392,831,244 | $383,394,844 | $364,775,134 | $335,412,321 |
| Liabilities | – | – | – | – |
| Payables | $156,869,715 | $154,747,431 | $144,616,691 | $132,866,874 |
| Short-Term Debt | $64,489,623 | $56,526,974 | $54,633,193 | $56,699,696 |
| Tax Payable | $0 | $2,988,672 | $3,278,676 | $3,008,108 |
| Deferred Revenue | $0 | $0 | $0 | $21,620,403 |
| Other Curr. Liab. | $29,016,250 | $27,227,560 | $32,434,397 | $5,111,468 |
| Total Curr. Liab. | $250,375,588 | $241,490,637 | $234,962,957 | $219,306,549 |
| LT Debt | $11,896,511 | $17,254,878 | $14,956,993 | $11,668,550 |
| Deferred Rev, NC | $0 | $448,241 | $493,847 | $462,740 |
| Deferred Tax Liab, NC | $0 | $788,379 | $936,744 | $1,022,792 |
| Other NC Liab. | $3,871,843 | $3,093,964 | $3,355,403 | $3,297,755 |
| Total NC Liab. | $15,768,354 | $21,585,462 | $19,742,987 | $16,451,837 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5,019,855 | $5,217,366 | $4,842,507 | $4,797,916 |
| Total Liabilities | $266,143,942 | $263,076,099 | $254,705,944 | $235,758,386 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $4,390,577 | $0 |
| Common Stock | $3,120,656 | $3,120,656 | $3,120,656 | $3,120,656 |
| Retained Earnings | $53,744,881 | $49,410,060 | $42,870,086 | $38,515,779 |
| AOCI | $22,022,096 | $0 | -$4,390,577 | -$4,388,067 |
| Other Equity | -$3,838 | $22,051,501 | $22,034,225 | $24,637,647 |
| Total Equity | $78,883,795 | $74,582,217 | $68,068,559 | $61,886,015 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $47,803,507 | $45,736,528 | $42,000,631 | $37,767,920 |
| Total Liab. & Tot. Equity | $392,831,244 | $383,394,844 | $364,775,134 | $335,412,321 |
| Net Debt | $22,072,775 | $9,973,314 | $14,368,562 | $24,838,818 |